DETECT - From Awareness to Action: Driving Multidisciplinary Application of Screening and Disease Modifying Therapies in Early Stage T1D
This DETECT T1D podcast series is designed to educate multidisciplinary clinicians on practical aspects of type 1 diabetes (T1D) screening, follow-up procedures, early referral, and administration of disease-modifying therapies. This episode features a conversation with Mrs. Amanda Troutman, whose son was screened for and diagnosed with stage 2 T1D and later treated with the disease-modifying treatment, teplizumab. Amanda recounts her family’s experience with the screening and treatment process and offers insights that can influence the care of patients with or at risk for developing T1D.
RELEASED DATE: June 20, 2025
EXPIRATION DATE: December 17, 2026
DETECT - From Awareness to Action: Driving Multidisciplinary Application of Screening and Disease Modifying Therapies in Early Stage T1D
This activity will bring together multidisciplinary expert clinicians, as well as a patient with type 1 diabetes (T1D), in order to overview opportunities for the practical application of T1D screening and to intervene early with disease-modifying therapies. In conversation with the faculty, the T1D patient will highlight their experience with T1D screening, what came next post-screening, as well as their journey to getting treatment to delay T1D progression. In addition, concise didactic presentations from faculty will be included to emphasize key concepts along this continuum of care in T1D.
RELEASED DATE: November 03, 2025
EXPIRATION DATE: November 03, 2026
DETECT - From Awareness to Action: Driving Multidisciplinary Application of Screening and Disease Modifying Therapies in Early Stage T1D
This enduring program focuses on enhancing clinicians’ ability to screen and identify early-stage type 1 diabetes (T1D). In addition, the program will overview T1D screening criteria, follow-up after screening results, and communicating effectively with patients to guide timely treatment decisions. Learners will also explore evidence-based criteria for selecting appropriate candidates for T1D disease-modifying therapies, implementing protocols to ensure their safe and efficient administration, as well as how to appropriately refer to specialty care to enable their earlier use.
RELEASED DATE: September 18, 2025
EXPIRATION DATE: September 18, 2026
DETECT - From Awareness to Action: Driving Multidisciplinary Application of Screening and Disease Modifying Therapies in Early Stage T1D
The DETECT T1D enduring activity unites multidisciplinary faculty and a type 1 diabetes (T1D) patient advocate to explore practical strategies for screening, follow-up, early referral, and treatment to delay T1D progression. The program addresses clinician and patient challenges to enhance early identification and optimize patient selection. Additionally, it provides access to our website with educational aids and resources to reinforce engagement and deepen understanding of evolving concepts in early-stage T1D management.
RELEASED DATE: November 07, 2025
EXPIRATION DATE: November 07, 2026
DETECT - From Awareness to Action: Driving Multidisciplinary Application of Screening and Disease Modifying Therapies in Early Stage T1D
Saturday, April 11, 2026
8:00 AM – 9:00 AM: Learning Gallery/Light Breakfast
9:00 AM – 12:30 PM: Continental Breakfast/CME Presentation/Lunch
12:30 PM – 1:00 PM: Learning Gallery
Renaissance Atlanta Midtown Hotel
866 W. Peachtree Street, NW
Atlanta, Georgia 30308
Meeting Room:
General Session: Centennial Ballroom
Learning Gallery: Centennial Ballroom Foyer
DETECT – Advances in The Delayed-Onset of Type 1 Diabetes: Strategies to Improve Awareness and Care for The Practicing Clinician
Wednesday, November 13, 2024
6:00 PM ET – 6:30 PM ET – Dinner & Registration
6:30 PM ET – 8:00 PM ET – CME Meeting
Sheraton Boston
39 Dalton Street
Boston, MA 02199
Meeting Room: Fairfax
DETECT – Advances in The Delayed-Onset of Type 1 Diabetes: Strategies to Improve Awareness and Care for The Practicing Clinician Copy
Wednesday, November 13, 2024
6:00 PM ET – 6:30 PM ET – Dinner & Registration
6:30 PM ET – 8:00 PM ET – CME Meeting
Sheraton Boston
39 Dalton Street
Boston, MA 02199
Meeting Room: Fairfax
DETECT T1D: From Awareness to Action: Driving Multidisciplinary Application of Screening and Disease Modifying Therapies in Early Stage T1D
This interactive TeleECHO series aims to help clinicians diagnose patients with early-stage type 1 diabetes (T1D) by screening for the presence of islet autoantibodies (IAbs) as well as identify patients with Stage 2 T1D eligible for treatment with the disease-modifying therapy, teplizumab, which is approved to delay progression to Stage 3 T1D. Real-world case examples and discussions are included to highlight various patient-specific characteristics that influence clinical recommendations related to screening and treatment.
RELEASED DATE: October 15, 2025
EXPIRATION DATE: October 15, 2026
DETECT T1D: From Awareness to Action: Driving Multidisciplinary Application of Screening and Disease Modifying Therapies in Early Stage T1D Copy
Friday, January 30, 2026
12:00PM – 1:00PM ET
Please note this TeleECHO program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
DETECT— Advances in the Delayed-Onset of Type 1 Diabetes: Strategies to Improve Awareness and Care for the Practicing Clinician
This educational program is designed to equip healthcare practitioners who care for patients with type 1 diabetes (T1D) with effective strategies for implementing timely screening protocols, including autoantibody screening, to facilitate early T1D diagnosis. Participants will gain expertise in safely integrating immunomodulatory agents into clinical practice while learning to monitor and prevent associated side effects. This distinctive program offers insights from both a diabetes expert and a patient/caregiver, providing a comprehensive perspective on T1D management.
RELEASED DATE: June 30, 2025
EXPIRATION DATE: June 30, 2026
